Keywords: ترکیبات دارویی; Antibiotics; Drug combinations; Interaction; Semi-mechanistic pharmacokinetic-pharmacodynamic modelling; Simulations;
مقالات ISI ترکیبات دارویی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ترکیبات دارویی; Synergy; Antagonism; Drug combinations; Higher-order interactions; Emergent interactions;
Keywords: ترکیبات دارویی; Drugged driving; Stratified survey; Drug combinations; Prevalence; New Zealand;
Keywords: ترکیبات دارویی; Drug combinations; Polymer drug conjugates; Synergy; Breast cancer; Gemcitabine; Doxorubcin;
Keywords: ترکیبات دارویی; PLD; phospholipidosis; DIPLD; drug-induced phospholipidosis; CAD(s); cationic amphiphilic drug(s); ADE(s); adverse drug effect(s); Drug-induced phospholipidosis; Polypharmacy; Drug combinations; In vitro; Adverse drug effects;
Keywords: ترکیبات دارویی; dezocine; morphine; postoperative analgesia; drug combinations
Keywords: ترکیبات دارویی; Hipertensión arterial; Control de la presión arterial; Oligoalbuminuria; Asociaciones farmacológicasHypertension; Blood pressure control; Microalbuminuria; Drug combinations
Keywords: ترکیبات دارویی; Anthelmintic pharmacology; Drug resistance; Drug combinations; Novel anthelmintics; Derquantel and monepantel;
Keywords: ترکیبات دارویی; Chemotherapy; Drug combinations; Polymer drug conjugate; Synergistic;
Keywords: ترکیبات دارویی; 2-aminophosphonovaleric acid (PubChem CID: 135342); Amlodipine (PubChem CID: 2162); Carbamazepine (PubChem CID: 2554); CGP 37849 (PubChem CID: 5950212); CGP 39551 (PubChem CID: 6372334); Clonazepam (PubChem CID: 2802); D cycloserine (PubChem CID: 6234); D
Keywords: ترکیبات دارویی; Synergy; Phytopharmaceuticals; Dose–effect relationship; Drug combinations; Multitargeting
Enhanced in vitro activity of tigecycline in the presence of chelating agents
Keywords: ترکیبات دارویی; Antibacterial; Drug combinations; Calcium chelation; Mechanistic investigation;
In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption
Keywords: ترکیبات دارویی; AMB; amphotericin B; DMSO; dimethyl sulfoxide; FIC; interaction index; IC50; half maximal inhibitory concentration; MIC; minimum inhibitory concentration that produce total death of the culture parasite; MTF; miltefosine; MTT; 3-(4,5-dimethylthiazol-2-yl)
Orthogonal Array composite design to study and optimize antioxidant combinations in the prevention of UVB-induced HSF damage
Keywords: ترکیبات دارویی; Antioxidants; Drug Combinations; Orthogonal Array Composite Design; Regression analysis; Skin cancer; UVB;
Towards repositioning of quinacrine for treatment of acute myeloid leukemia - Promising synergies and in vivo effects
Keywords: ترکیبات دارویی; Acute myeloid leukemia; Quinacrine; Repositioning; Drug combinations;
Combination Therapy of Rosuvastatin and Ezetimibe in Patients with High Cardiovascular Risk
Keywords: ترکیبات دارویی; cardiovascular diseases; cholesterol; drug combinations; ezetimibe; LDL; rosuvastatin calcium;
Overcoming ABC transporter-mediated multidrug resistance: The dual role of tyrosine kinase inhibitors as multitargeting agents
Keywords: ترکیبات دارویی; MDR; BCR-ABL inhibitors; EGFR inhibitors; VEGFR inhibitors; Drug combinations; ABC; ATP binding cassette; ADME-tox; absorption, distribution, metabolism, excretion, toxicity; AKT; v-akt murine thymoma viral oncogene homolog; ALL; acute lymphoblastic leuke
PDC-SGB: Prediction of effective drug combinations using a stochastic gradient boosting algorithm
Keywords: ترکیبات دارویی; Drug combinations; Feature selection; Stochastic gradient boosting; Feature patterns;
Morphological changes and differentially expressed efflux pump genes in Mycobacterium tuberculosis exposed to a rifampicin and verapamil combination
Keywords: ترکیبات دارویی; Mycobacterium tuberculosis; Efflux pump; Morphological changes; Gene expression; Drug combinations;
DAFODIL: A novel liposome-encapsulated synergistic combination of doxorubicin and 5FU for low dose chemotherapy
Keywords: ترکیبات دارویی; Drug combinations; Synergistic; Chemotherapy; Liposomes; Nanoparticles;
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Keywords: ترکیبات دارویی; drug combinations; inhibitor; drug discovery; antibacterial;
PARP inhibitor combination therapy
Keywords: ترکیبات دارویی; PARP inhibitor; Drug combinations; BRCA1; BRCA2;
Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models
Keywords: ترکیبات دارویی; ErbB2; Her2/Neu; Breast cancer; HSP90; 17-AAG; Doxorubicin; Block copolymers; Nanogels; Drug combinations
Combined effects of modafinil and d-amphetamine in male Sprague-Dawley rats trained to discriminate d-amphetamine
Keywords: ترکیبات دارویی; Modafinil; d-Amphetamine; Drug discrimination; Training dose; Drug combinations;
Combining ibuprofen and acetaminophen for acute pain management after third-molar extractions : Translating clinical research to dental practice
Keywords: ترکیبات دارویی; Ibuprofen; acetaminophen; analgesics; drug combinations; practice guidelinesAPAP, Acetaminophen or N-acetyl-p-aminophenol; COX, Cyclooxygenase; FDA, Food and Drug Administration; NNT, Number needed to treat; NSAID, Nonsteroidal anti-inflammatory drug; OTC
Strategies for the design of orally bioavailable antileishmanial treatments
Keywords: ترکیبات دارویی; AmB, amphotericin B; CL, cutaneous leishmaniasis; DDS, drug delivery system; HePC, hexadecylphosphocholine (miltefosine); VL, visceral leishmaniasisVisceral leishmaniasis; Drug combinations; Oral administration; Nanoparticles
CommentaryDevelopment and therapeutic impact of HDAC6-selective inhibitors
Keywords: ترکیبات دارویی; HDAC inhibitors; Histone deacetilase 6; Antitumor therapy; Drug combinations; Drug design;
In vitro activity of nicotinamide/antileishmanial drug combinations
Keywords: ترکیبات دارویی; Nicotinamide; Antimonials; Leishmania; Drug combinations;
Potentiation of buprenorphine antinociception with ultra-low dose naltrexone in healthy subjects
Keywords: ترکیبات دارویی; Opioids; Antinociception; Human experimental pain; Drug combinations; Buprenorphine; Naltrexone;
Cost-Effectiveness of Nucleoside Reverse Transcriptase Inhibitor Pairs in Efavirenz-Based Regimens for Treatment-Naïve Adults with HIV Infection in the United States
Keywords: ترکیبات دارویی; AIDS; cost-effectiveness analysis; drug combinations; Markov model;
Associate Editor: Garth PowisTargeting EGFR and VEGF(R) pathway cross-talk in tumor survival and angiogenesis
Keywords: ترکیبات دارویی; EGFR; VEGF(R); Molecular targeted anticancer agents; Monoclonal antibodies; Tyrosine kinase inhibitors; Signaling cross-talk; Tumor cell survival; Tumor angiogenesis; Drug combinations; CRC; colorectal cancer; ECs; endothelial cells; EGF; epidermal growth
In vitro susceptibility of clinically important zygomycetes to combinations of amphotericin B and suramin
Keywords: ترکیبات دارویی; Zygomycetes; Suramin; Amphotericin B; Drug combinations; MICZygomycètes; Suramine; Amphotéricine B; Combinaison d’antifongiques; CMI
Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies
Keywords: ترکیبات دارویی; Bacterial drug resistance; Microbial sensitivity tests; Drug combinations; Cystic fibrosis; Pneumonia; Metallo-β-lactamases
Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo
Keywords: ترکیبات دارویی; Pyronaridine; Artesunate; Malaria; Plasmodium falciparum; Drug combinations
Efficacy of sulfadoxine-pyrimethamine, amodiaquine, and sulfadoxine-pyrimethamine–amodiaquine combination for the treatment of uncomplicated falciparum malaria in the urban and suburban areas of Brazzaville (Congo)
Keywords: ترکیبات دارویی; Drug resistance; Clinical study; Plasmodium falciparum; Chloroquine; Drug combinations
Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis
Keywords: ترکیبات دارویی; Schistosomiasis; Soil-transmitted helminthiasis; Lymphatic filariasis; Onchocerciasis; Efficacy; Safety; Drug combinations;
A combination solution for routine pupillary dilation
Keywords: ترکیبات دارویی; Diagnostic tests, routine; Drug combinations; Ophthalmoscopy; Phenylephrine; Tropicamide
Modèles expérimentaux : quels modèles peuvent encore apporter des informations dans le traitement des infections bactériennes ?
Keywords: ترکیبات دارویی; Antibiotiques; Modèle animal expérimental; Pharmacodynamie; Pharmacocinétique; Résistance antibiotique; Association d'antibiotiques; Antibiotics; Experimental animal models; Pharmacodynamics; Pharmacokinetics; Antibiotic resistance; Drug combinations;
Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use
Keywords: ترکیبات دارویی; Leishmania; Miltefosine; Experimental drug resistance; Aminophospholipid translocase; CDC50 family; Control; Drug combinations; LdMT; LdRos3
In vitro antimycobacterial activity of newly synthesised S-alkylisothiosemicarbazone derivatives and synergistic interactions in combination with rifamycins against Mycobacterium avium
Keywords: ترکیبات دارویی; Mycobacterium avium; S-Alkylisothiosemicarbazone derivatives; Rifamycins; In vitro activity; Drug combinations;
The potential of statins as part of anti-cancer treatment
Keywords: ترکیبات دارویی; Statins; Anti-tumour activity; Solid tumours; Drug combinations;
Stability of metronidazole, tetracycline HCl and famotidine alone and in combination
Keywords: ترکیبات دارویی; Stability; Compatibility; pH-solubility; Metronidazole; Tetracycline HCl; Famotidine; Drug combinations;